InvestorsHub Logo
Followers 8
Posts 190
Boards Moderated 0
Alias Born 10/30/2005

Re: rancherho post# 5003

Wednesday, 11/07/2007 7:07:27 PM

Wednesday, November 07, 2007 7:07:27 PM

Post# of 12660
Too little of a good thing (macrophage activation) can also be a bad thing.See a new study published in Nature: http://www.nature.com/nm/journal/v13/n11/abs/nm1677.html
and: http://cebp.aacrjournals.org/cgi/content/abstract/15/4/711

One of the distinct impacts of Taxotere according to Dr. Petrylak and others in increased macrophage activation, as opposed to the macrophage inhibition described in these two studies.Taxotere also interferes with mitosis leading to the apoptosis of Tregs rapidly proliferating in response to a T cell based immune attack. Taxotere also reportedly counters the bcl-2 anti-apoptosis expression of AIPC cells. The B cell / antibody marking of cancer cell antigens associated with both GVAX and Provenge also leads to cancer cell destruction by macrophages.All of this suggests that there is good theoretical support for the synergistic effects of immunotherapies and Taxotere even if the combination of Asentar and Taxotere causes serious problems. JMHO.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.